Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion | RCV001807962 | SCV002058284 | likely pathogenic | Focal segmental glomerulosclerosis 7 | 2024-04-17 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. The variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported (PMID: 22213154). In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.91; 3Cnet: 0.98]. Same nucleotide change resulting in same amino acid change has been previously reported to be associated with PAX2 related disorder (PMID: 33997468). The variant has been reported to co-segregate with the disease in at least 3 similarly affected relatives/individuals in the same family or similarly affected unrelated families (PMID: 33997468). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. |